Adar Poonawalla, the chief executive of Serum, said in January that the vaccine, named Corovax, was expected to be launched by June. Today, Poonawalla said the trials of Corovax had kicked off in India, but did not say why the vaccine launch was delayed.
“It has been tested against African and UK variants of Covid-19 and has an overall efficacy of 89%,” tweeted Poonawalla, whose Serum Institute is the world’s largest manufacturer of vaccines. “Hope to launch by September 2021!”
Poonawalla said earlier this month that a temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines such as Novavax.
India, the world’s biggest vaccine maker, said yesterday it would prioritise domestic Covid inoculations amid rising coronavirus case and had told international buyers of its decision.